Getinge announces results from SEMPER FI pilot study of intra-aortic balloon pump showing numerical trend toward reduced mortality in patients with extensive myocardial infarction and persistent ischemia

Study results presented at EuroPCR 2018 WAYNE, New Jersey, May 25, 2018 /PRNewswire/ -- Getinge, a leading global provider of innovative medical technology, today announced results from the Survival Improvement in Extensive Myocardial Infarction with PERsistent Ischemia Following IABP...

from PR Newswire: //https://ift.tt/2INktHy